Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis
Launched by NOVARTIS · Sep 13, 2005
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Key Inclusion criteria:
- • • Osteoarthritis of the hand
- Key Exclusion Criteria:
- • Other rheumatic disease, such as rheumatoid arthritis
- • Active gastrointestinal ulcer during the last year
- • Known allergy to analgesic drugs
About Novartis
Novartis is a global healthcare company based in Switzerland, dedicated to reimagining medicine to improve and extend people's lives. With a strong focus on innovative pharmaceuticals, Novartis engages in the research, development, and commercialization of a wide range of therapies across various therapeutic areas, including oncology, cardiology, immunology, and neuroscience. The company is committed to advancing clinical research through rigorous trials that prioritize patient safety and efficacy, aiming to deliver groundbreaking treatments and solutions that address unmet medical needs worldwide. Novartis's commitment to innovation and collaboration positions it at the forefront of the biopharmaceutical industry, driving advancements that enhance patient care and health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karlsruhe, , Germany
Berlin, , Germany
Bochum, , Germany
Dortmund, , Germany
Bad Hersfeld, , Germany
Nantes, , France
Paris, , France
Bad Nauheim, , Germany
Hamburg, Hh, Germany
Paris, , France
Cergy, , France
Clamart, , France
Cournonterral, , France
Fellering, , France
Goussonville, , France
Linas, , France
Longpont Sur Orge, , France
Meaux, , France
Nantes, , France
Orly, , France
Savigny Sur Orge, , France
Thouars, , France
Villeneuve Le Roi, , France
Berlin, , Germany
Dinslaken, , Germany
Dreieich, , Germany
Dresden, , Germany
Frankfurt A/M, , Germany
Hagen, , Germany
Hamburg, , Germany
Karlsruhe, , Germany
Kassel, , Germany
Leipzig, , Germany
Ludwigshafen, , Germany
München, , Germany
Neustadt/Aisch, , Germany
Nürnberg, , Germany
Stuttgart, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials